•
Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), a Chinese bioengineering company, has announced that its subsidiary, Technogenetics S.P.A. (TGS), is poised to acquire an additional 20% stake in TGS. The stake is currently held by Altergon Italia S.r.l., and the transaction is valued at EUR 15.34 million (USD 16.4 million).…